Lv1
68 积分 2025-11-02 加入
Real-World Experience with Lecanemab for Alzheimer's Disease
17天前
已关闭
Initial Experience with Lecanemab and Lessons Learned in 71 Patients in a Regional Medical Center
18天前
已关闭
Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study
20天前
已完结
Lecanemab in Clinical Practice: Real-World Treatment Outcomes from a Retrospective Neurological Clinic Case Series Review in Early Alzheimer’s Disease (P12-3.008)
22天前
已完结
Real-World Experience with Lecanemab for Alzheimer's Disease
22天前
已关闭
Approaching 18 months of lecanemab and 6 months of donanemab in Japan: Key considerations for late-breaking insights
22天前
已关闭
Lecanemab Eligibility in Korean Memory Clinic and Research Populations: A Retrospective Analysis
22天前
已完结
A Systematic Review of the Efficacy and Safety of Anti-amyloid Monoclonal Antibodies in Alzheimer's Disease
30天前
已完结
Real‐World Effectiveness and Safety of JAK Inhibitors in Atopic Dermatitis: A Systematic Review and Meta‐Analysis
30天前
已完结
Artesunate alleviates Parkinson's disease by targeting astrocyte MT2A to attenuate dopamine neuronal cuproptosis
2个月前
已完结
皖公网安备34019202002308
